Table 4. Prevalence of patient-reported medication use (in the past 90 days) for sinusitis at baseline and follow-up study evaluations (n=75).
Baseline | Last Available Follow-up (≥6 months) | ||
---|---|---|---|
Medication regimen: | n (%) | n (%) | p-value |
Topical nasal steroid sprays | 56 (75%) | 45 (60%) | 0.035 |
Topical nasal steroid drops/irrigations | 22 (29%) | 28 (37%) | 0.286 |
Decongestants | 35 (47%) | 28 (37%) | 0.230 |
Oral antibiotics | 41 (55%) | 20 (27%) | <0.001 |
Oral/systemic corticosteroid | 38 (51%) | 15 (20%) | <0.001 |
Antihistamines | 39 (52%) | 27 (36%) | 0.008 |
Leukotriene modifiers | 19 (25%) | 18 (24%) | >0.999 |
Saline irrigations rinse | 63 (84%) | 57 (76%) | 0.210 |
p-value represents significance using McNemar's chi-square test statistics